Back to Search Start Over

Validation of a Commercially Available Indirect Elisa Using a Nucleocapside Recombinant Protein for Detection of Schmallenberg Virus Antibodies.

Authors :
Bréard, Emmanuel
Lara, Estelle
Comtet, Loïc
Viarouge, Cyril
Doceul, Virginie
Desprat, Alexandra
Vitour, Damien
Pozzi, Nathalie
Cay, Ann Brigitte
De Regge, Nick
Pourquier, Philippe
Schirrmeier, Horst
Hoffmann, Bernd
Beer, Martin
Sailleau, Corinne
Zientara, Stéphan
Source :
PLoS ONE; Jan2013, Vol. 8 Issue 1, Special section p1-5, 5p
Publication Year :
2013

Abstract

A newly developed Enzym Like Immuno Sorbant Assay (ELISA) based on the recombinant nucleocapsid protein (N) of Schmallenberg virus (SBV) was evaluated and validated for the detection of SBV-specific IgG antibodies in ruminant sera by three European Reference Laboratories. Validation data sets derived from sheep, goat and bovine sera collected in France and Germany (n = 1515) in 2011 and 2012 were categorized according to the results of a virus neutralization test (VNT) or an indirect immuno-flurorescence assay (IFA). The specificity was evaluated with 1364 sera from sheep, goat and bovine collected in France and Belgium before 2009. Overall agreement between VNT and ELISA was 98.9% and 98.3% between VNT and IFA, indicating a very good concordance between the different techniques. Although cross-reactions with other Orthobunyavirus from the Simbu serogroup viruses might occur, it is a highly sensitive, specific and robust ELISA-test validated to detect anti-SBV antibodies. This test can be applied for SBV sero-diagnostics and disease-surveillance studies in ruminant species in Europe. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
19326203
Volume :
8
Issue :
1
Database :
Complementary Index
Journal :
PLoS ONE
Publication Type :
Academic Journal
Accession number :
85382738
Full Text :
https://doi.org/10.1371/journal.pone.0053446